I don’t have access to real‑time pricing, but I can give you a general sense of what to expect and how to find the most accurate, up‑to‑date numbers for your situation.
| Region | Approximate Cost (per 30‑day supply) | Notes |
|--------|--------------------------------------|-------|
| United States | $5,000 – $12,000 | Prices can vary widely depending on pharmacy, insurance coverage, formulary status, and whether a copay, coinsurance, or manufacturer discount program is applied. |
| Canada | CAD 3,000 – CAD 7,000 | Many provinces cover the drug under provincial drug plans, but the exact amount depends on the province’s formulary and patient assistance programs. |
| European Union | €1,800 – €3,800 | Costs differ by country; some have negotiated lower prices through national health services or price‑matching agreements. |
| Australia | AUD 4,500 – AUD 10,000 | The Pharmaceutical Benefits Scheme (PBS) may cover a portion, but the patient’s out‑of‑pocket cost varies. |
How to find the exact price that applies to you
1. Ask your oncologist or pharmacy
The prescribing physician’s office or the dispensing pharmacy can often give a “list price” or an estimate based on your insurance plan.
2. Check your insurance or pharmacy benefit manager
Many insurers publish drug formulary lists with copays and coinsurance amounts. If you’re on a Medicare Part D plan, the plan’s website will show the copay for brand‑name drugs like osimertinib.
3. Use online price‑comparison tools
Websites such as GoodRx (U.S.), Drugs.com, or Medisafe can give a range of prices from different pharmacies in your area.
4. Explore patient assistance programs
- Amgen’s “Amgen Patient Assistance Program” (Amgen makes osimertinib) offers discounts and copay support to qualified patients who cannot afford the drug.
- RxAssist or Patient Advocate Foundation also provide resources for negotiating lower costs and applying for manufacturer coupons.
5. Consider generic or alternative options
If a generic version of osimertinib becomes available (unlikely in the near term due to patent protections), it may be significantly cheaper. Some clinicians may prescribe an alternative targeted therapy that is more affordable while still effective.
6. Ask about clinical trials
Participation in a clinical trial can provide access to the drug at no cost or a reduced cost, though eligibility is limited to specific criteria.
Why the price can be so high
- Research & Development: Targeted therapies like osimertinib involve expensive development, clinical trials, and regulatory approval processes.
- Patent Protection: Until the patent expires, the manufacturer can set the price to recoup investment.
- Specialized Formulation: The drug requires a precise, low‑dose formulation that is expensive to produce.
- Market Dynamics: The oncology market often sees higher prices due to the life‑saving nature of the drug and limited competition.
Bottom line
- US: Roughly $5,000–$12,000 per month before insurance; the actual out‑of‑pocket cost can be far lower if you have coverage.
- Canada/Europe/Australia: Prices are generally lower but still substantial; provincial or national programs often cover a large portion.
If you have a specific insurance plan, the next step is to call the insurer’s customer service or visit their website to pull the exact copay and coverage details. From there you can compare pharmacies, look into assistance programs, and make an informed decision about how to manage the cost.